Type I interferon regulation of group I ILC subsets during both homeostasis and cytomegalovirus infection
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf051 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Remi Marrocco und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Innovation and Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States. Hauptthemen laut MEDLINE: Homeostasis, Muromegalovirus, Cytomegalovirus Infections, Killer Cells, Natural. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Type 1 innate lymphoid cells (ILC1s) and conventional natural killer cells belong to the group 1 ILCs (gILC1), characterized largely by T-bet expression and interferon γ secretion. While much has been done to define factors that regulate the development, differentiation, and effector functions of both cell types, little is known about what controls gILC1 homeostasis. Here, mixed bone marrow chimeras were used to define the role of type I interferon receptor (IFNAR) signaling in regulating gILC1 in the spleen and liver at homeostasis and during murine cytomegalovirus infection. We show that basal IFNAR signaling induces cell and tissue-specific phenotypic changes in gILC1, inhibiting bona-fide ILC1 markers (CD49a, CD200R, CXCR6) and regulating expression of perforin and granzymes B and C. Finally, while IFNAR signaling enhances cytokine responsiveness in vitro in both gILC1 subsets, it has a dichotomous effect on interferon γ production during murine cytomegalovirus infection, stimulating it in conventional natural killer cells and inhibiting it in ILC1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vaccine Innovation and Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Marrocco, R., Lucero-Meza, E., & Benedict, C. A. (2025). Type I interferon regulation of group I ILC subsets during both homeostasis and cytomegalovirus infection. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf051
Vancouver
Marrocco R, Lucero-Meza E, Benedict CA. Type I interferon regulation of group I ILC subsets during both homeostasis and cytomegalovirus infection. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf051
BibTeX
@article{Marrocco2025,
author = {Marrocco, Remi and Lucero-Meza, Eduardo and Benedict, Chris A},
title = {Type I interferon regulation of group I ILC subsets during both homeostasis and cytomegalovirus infection},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf051}
}
EUVIMED